{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T21:41:12Z","timestamp":1776289272962,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["305499"],"award-info":[{"award-number":["305499"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpba.2025.116947","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T11:13:12Z","timestamp":1746875592000},"page":"116947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Urinary proteomics in kidney transplant recipients and influence of demographics and treatments as potential confounders of graft lesions"],"prefix":"10.1016","volume":"264","author":[{"given":"Fran\u00e7ois-Ludovic","family":"Sauvage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Labriffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dany","family":"Anglicheau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried","family":"Gwinner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116947_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/ki.2010.274","article-title":"Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients","volume":"78","author":"van Ham","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.jpba.2025.116947_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204204","article-title":"Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: a cross-sectional study","volume":"13","author":"Lim","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.116947_bib3","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00345-014-1263-z","article-title":"Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation","volume":"32","author":"Stubendorff","year":"2014","journal-title":"World J. Urol."},{"key":"10.1016\/j.jpba.2025.116947_bib4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1681\/ASN.2009080876","article-title":"Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection","volume":"21","author":"Ling","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2025.116947_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/intimm\/dxaa032","article-title":"Increased urinary exosomal SYT17 levels in chronic active antibody-mediated rejection after kidney transplantation via the IL-6 amplifier","volume":"32","author":"Takada","year":"2020","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jpba.2025.116947_bib6","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.ekir.2020.06.018","article-title":"Urinary protein biomarker panel for the diagnosis of antibody-mediated rejection in kidney transplant recipients","volume":"5","author":"Mertens","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.jpba.2025.116947_bib7","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.3390\/biomedicines10102346","article-title":"Urinary exosomal cystatin C and lipopolysaccharide binding protein as biomarkers for antibody-mediated rejection after kidney transplantation","volume":"10","author":"Kim","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.jpba.2025.116947_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104208","article-title":"Urinary epidermal growth factor is a novel biomarker for early diagnosis of antibody mediated kidney allograft rejection: a urinary proteomics analysis","volume":"240","author":"Heidari","year":"2021","journal-title":"J. Proteom."},{"key":"10.1016\/j.jpba.2025.116947_bib9","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1681\/ASN.2014080797","article-title":"Urinary C-X-C motif chemokine 10 independently improves the noninvasive diagnosis of antibody-mediated kidney allograft rejection","volume":"26","author":"Rabant","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2025.116947_bib10","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1111\/ajt.15959","article-title":"Development and validation of an optimized integrative model using urinary chemokines for noninvasive diagnosis of acute allograft rejection","volume":"20","author":"Tinel","year":"2020","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.jpba.2025.116947_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.604353","article-title":"Deciphering the prognostic and predictive value of urinary CXCL10 in kidney recipients with BK virus reactivation","volume":"11","author":"Tinel","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.jpba.2025.116947_bib12","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.3389\/ti.2023.12115","article-title":"European Society of Organ Transplantation Consensus Statement on testing for non-invasive diagnosis of kidney allograft rejection","volume":"36","author":"Park","year":"2023","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jpba.2025.116947_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/TP.0b013e3181e6424d","article-title":"Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts","volume":"90","author":"Ho","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.jpba.2025.116947_bib14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/proteomes9030032","article-title":"A novel urinary proteomics classifier for non-invasive evaluation of interstitial fibrosis and tubular atrophy in chronic kidney disease","volume":"9","author":"Catanese","year":"2021","journal-title":"Proteomes"},{"key":"10.1016\/j.jpba.2025.116947_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4174\/astr.2019.97.1.27","article-title":"Urinary transglutaminase 2 as a potent biomarker to predict interstitial fibrosis and tubular atrophy of kidney allograft during early posttransplant period in deceased donor kidney transplantation","volume":"97","author":"Kim","year":"2019","journal-title":"Ann. Surg. Treat. Res."},{"key":"10.1016\/j.jpba.2025.116947_bib16","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1097\/TP.0000000000002676","article-title":"Urine angiotensin II signature proteins as markers of fibrosis in kidney transplant recipients","volume":"103","author":"Mohammed-Ali","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jpba.2025.116947_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12014-024-09462-z","article-title":"Recent progress in mass spectrometry-based urinary proteomics","volume":"21","author":"Joshi","year":"2024","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.jpba.2025.116947_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116911","article-title":"A thorough clinical study pipeline to discover and validate biomarkers in kidney transplantation: the European BIOMARGIN program","author":"Marquet","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116947_bib19","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1074\/mcp.M500061-MCP200","article-title":"Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein","volume":"4","author":"Ishihama","year":"2005","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.jpba.2025.116947_bib20","article-title":"A comprehensive urine proteome database generated from patients with various renal conditions and prostate cancer","volume":"8","author":"Swensen","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.jpba.2025.116947_bib21","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1681\/ASN.2016091018","article-title":"Insights into diabetic kidney disease using urinary proteomics and bioinformatics","volume":"28","author":"Van","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2025.116947_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1681\/ASN.0000000000000260","article-title":"Prognostic biomarkers in kidney transplantation: a systematic review and critical appraisal","volume":"35","author":"Raynaud","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jpba.2025.116947_bib23","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpba.2025.116947_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.101925","article-title":"Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer","volume":"44","author":"Wei","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jpba.2025.116947_bib25","doi-asserted-by":"crossref","DOI":"10.1074\/mcp.M110.003467","article-title":"The surprising composition of the salivary proteome of preterm human newborn","volume":"10","author":"Castagnola","year":"2011","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.jpba.2025.116947_bib26","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11306-015-0829-0","article-title":"Gender-specific pathway differences in the human serum metabolome","volume":"11","author":"Krumsiek","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.jpba.2025.116947_bib27","doi-asserted-by":"crossref","first-page":"20357","DOI":"10.1038\/s41598-024-70390-x","article-title":"Transforming kidney transplant monitoring with urine CXCL9 and CXCL10: practical clinical implementation","volume":"14","author":"Tinel","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2025.116947_bib28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arr.2016.04.010","article-title":"Lysosomal cathepsins and their regulation in aging and neurodegeneration","volume":"32","author":"Stoka","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jpba.2025.116947_bib29","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202357265","article-title":"Lysosomes in senescence and aging","volume":"24","author":"Tan","year":"2023","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jpba.2025.116947_bib30","doi-asserted-by":"crossref","first-page":"6297","DOI":"10.1074\/jbc.273.11.6297","article-title":"Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha","volume":"273","author":"Kang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jpba.2025.116947_bib31","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/jth.13265","article-title":"The influence of corticosteroids on hemostasis in healthy subjects","volume":"14","author":"Majoor","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jpba.2025.116947_bib32","article-title":"ILP-2: a new bane and therapeutic target for human cancers","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jpba.2025.116947_bib33","doi-asserted-by":"crossref","first-page":"8832114","DOI":"10.1155\/2021\/8832114","article-title":"Tacrolimus protects podocytes from apoptosis via downregulation of TRPC6 in diabetic nephropathy","volume":"2021","author":"Ma","year":"2021","journal-title":"J. Diabetes Res."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:15:30Z","timestamp":1762308930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":33,"alternative-id":["S0731708525002882"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116947","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary proteomics in kidney transplant recipients and influence of demographics and treatments as potential confounders of graft lesions","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116947"}}